Full patient enrolment in Phase IIa Menstrual Migraine study
Asarina Pharma AB has reached full patient enrolment in its Phase IIa menstrual migraine (MM) study. 158 women have been...
Read MoreObs Gynae & Midwifery News (OGMN) is a leading trade title in the field of obstetrics, gynaecology, midwifery and women’s health
Having been at the forefront of this critical field for over a decade as its leading trade title, Obs Gynae & Midwifery News is now an exclusively digital platform.